Teleflex Incorporated Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith...
February 23 2017 - 6:15AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, announced today
that Benson Smith will retire from his position as Chief Executive
Officer, effective on December 31, 2017. Mr. Smith, a Teleflex
Board member since 2005, will continue to serve as Teleflex’s
Chairman of the Board. He has been nominated by Teleflex’s Board of
Directors to serve for another three year term if elected by
Teleflex’s stockholders at the 2017 annual meeting to be held in
May, 2017.
“I want to thank the Board of Directors, along with all of our
employees and shareholders, for the opportunity to serve on the
executive management team at Teleflex,” said Mr. Smith. “When I
began my tenure as CEO in 2011, Teleflex was completing its
transition from a diversified industrial company, and I’m proud
that in less than a decade we have been able to successfully grow
into our current position as a leading global provider of medical
devices. I have tremendous confidence in my colleague, Liam Kelly,
and the talented executives that we have been able to attract and
develop at Teleflex, and I look forward to Teleflex’s continued
success under Liam’s leadership and strategic guidance.”
Liam Kelly, who currently serves as Teleflex’s President and
Chief Operating Officer, has been named by the Teleflex Board of
Directors to succeed Mr. Smith as Chief Executive Officer following
Mr. Smith’s retirement.
“I’m grateful to Benson for his years of leadership as CEO,
under which Teleflex has continuously expanded and improved its
capabilities as a diversified, global provider of medical
technologies, and I’m excited by the prospect of leading Teleflex
through the Company’s next stage of growth and development,” said
Mr. Kelly.
ABOUT TELEFLEX INCORPORATED
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation - a relentless pursuit of identifying
unmet clinical needs - to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® - trusted brands united by a common
sense of purpose.
CAUTION CONCERNING FORWARD-LOOKING INFORMATION
This press release contains forward-looking statements,
including, but not limited to, statements related to the occurrence
of, and arrangements related to, Mr. Smith’s retirement as, and Mr.
Kelly’s designation as, Teleflex’s Chief Executive Officer.. Actual
results could differ materially from those in the forward-looking
statements due to, among other things, the stockholder vote at
Teleflex’s 2017 annual meeting and other factors described or
incorporated in our filings with the Securities and Exchange
Commission (“SEC”), including our Annual Report on Form 10-K for
the year ended December 31, 2015.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170223005009/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President
of Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024